TABLE OF CONTENTS
1 INTRODUCTION 15
1.1 OBJECTIVES OF THE STUDY 15
1.2 MARKET DEFINITION 15
1.3 MARKET SCOPE 16
1.3.1 MARKETS COVERED 16
1.3.2 YEARS CONSIDERED FOR THE STUDY 17
1.4 CURRENCY 17
1.5 LIMITATIONS 18
1.6 STAKEHOLDERS 18
2 RESEARCH METHODOLOGY 19
2.1 RESEARCH DATA 19
2.1.1 SECONDARY RESEARCH 20
2.1.1.1 Key data from secondary sources 20
2.1.2 PRIMARY RESEARCH 20
2.1.2.1 Key data from primary sources 21
2.1.2.1.1 Breakdown of Primary Interviews 21
2.2 MARKET SIZE ESTIMATION 22
2.2.1 REVENUE-BASED MARKET ESTIMATION 22
2.2.2 END-USER-BASED MARKET ESTIMATION 22
2.2.3 PRIMARY RESEARCH VALIDATION 23
2.3 MARKET BREAKDOWN AND DATA TRIANGULATION 24
2.4 ASSUMPTIONS FOR THE STUDY 25
3 EXECUTIVE SUMMARY 26
4 PREMIUM INSIGHTS 30
4.1 PROTEIN SEQUENCING MARKET OVERVIEW 30
4.2 PROTEIN SEQUENCING MARKET, BY PRODUCT & SERVICE (2018 VS. 2023) 30
4.3 PROTEIN SEQUENCING MARKET, BY TECHNOLOGY, 2018 VS. 2023 31
4.4 PROTEIN SEQUENCING MARKET, BY APPLICATION, 2018 VS. 2023 31
4.5 PROTEIN SEQUENCING MARKET, BY END USER, 2018 VS. 2023 32
5 MARKET OVERVIEW 33
5.1 INTRODUCTION 33
5.2 MARKET DYNAMICS 33
5.2.1 DRIVERS 34
5.2.1.1 Increasing focus on target-based drug development by pharmaceutical and biotechnology companies 34
5.2.1.2 Advancements in clinical mass spectrometry and analytical techniques 34
5.2.1.3 Increasing public-private financial support for proteomic research 34
5.2.2 RESTRAINTS 35
5.2.2.1 High infrastructure costs 35
5.2.3 OPPORTUNITIES 36
5.2.3.1 Technological advancements for the identification of isobaric residues in protein sequences 36
5.2.4 CHALLENGES 36
5.2.4.1 Preparation of pure protein samples 36
5.2.4.2 Need for skilled researchers and laboratory professionals 36
6 PROTEIN SEQUENCING MARKET, BY PRODUCT & SERVICE 37
6.1 INTRODUCTION 38
6.2 SAMPLE PREPARATION PRODUCTS & SERVICES 39
6.2.1 GROWING NEED FOR STANDARDIZED SAMPLE PREPARATION SOLUTIONS IS A MAJOR DRIVER FOR THE SAMPLE PREPARATION PRODUCTS & SERVICES MARKET 39
6.3 PROTEIN SEQUENCING PRODUCTS 40
6.3.1 REAGENTS & CONSUMABLES 41
6.3.1.1 Growing number of sequencing procedures to drive the demand for protein sequencing reagents & consumables 41
6.3.2 INSTRUMENTS 41
6.3.2.1 Mass spectrometry instruments 42
6.3.2.1.1 Technological advancements to drive the adoption of mass spectrometry instruments 42
6.3.2.2 Edman degradation sequencers 43
6.3.2.2.1 High accuracy of Edman degradation method to drive the adoption of these products 43
6.3.3 ANALYSIS PRODUCTS/SOFTWARE 44
6.3.3.1 Protein sequencing analysis products/software to witness the highest growth rate during the forecast period 44
6.4 PROTEIN SEQUENCING SERVICES 45
6.4.1 PROTEIN SEQUENCING SERVICES TO REGISTER THE HIGHEST GROWTH BETWEEN 2018 & 2023 45
7 PROTEIN SEQUENCING MARKET, BY TECHNOLOGY 46
7.1 INTRODUCTION 47
7.2 MASS SPECTROMETRY 48
7.2.1 HIGH-THROUGHPUT SEQUENCING CAPABILITIES AND COST EFFICIENCY TO DRIVE THE ADOPTION OF MASS SPECTROMETRY PROTEIN SEQUENCING 48
7.3 EDMAN DEGRADATION 49
7.3.1 HIGH ACCURACY OF THE EDMAN DEGRADATION METHOD IS THE KEY FACTOR DRIVING ITS ADOPTION IN THE MARKET 49
8 PROTEIN SEQUENCING MARKET, BY APPLICATION 50
8.1 INTRODUCTION 51
8.2 BIOTHERAPEUTICS 52
8.2.1 BIOTHERAPEUTICS SEGMENT TO WITNESS THE HIGHEST GROWTH DURING THE FORECAST PERIOD 52
8.3 GENETIC ENGINEERING 52
8.3.1 LARGE NUMBER OF RESEARCH PROJECTS FOCUSED ON GENETICALLY MODIFIED ORGANISMS & TECHNOLOGICAL ADVANCEMENTS—KEY FACTORS DRIVING MARKET GROWTH 52
8.4 OTHER APPLICATIONS 54
9 PROTEIN SEQUENCING MARKET, BY END USER 56
9.1 INTRODUCTION 57
9.2 ACADEMIC INSTITUTES & RESEARCH CENTERS 58
9.2.1 ACADEMIC INSTITUTES & RESEARCH CENTERS TO ACCOUNT FOR THE LARGEST SHARE OF THE MARKET OWING TO THE INCREASING FUNDING FOR PROTEOMICS RESEARCH 58
9.3 PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES 60
9.3.1 INCREASING R&D EXPENDITURE OF MAJOR PHARMACEUTICAL AND BIOTECHNOLOGY COMPANIES TO DRIVE MARKET GROWTH 60
9.4 OTHER END USERS 61
10 PROTEIN SEQUENCING MARKET, BY REGION 62
10.1 INTRODUCTION 63
10.2 NORTH AMERICA 64
10.2.1 US 67
10.2.1.1 Launch of advanced protein sequencing products & the strong presence of leading players are driving the growth of the protein sequencing market in the US 67
10.2.2 CANADA 68
10.2.2.1 Financial support from government and private organizations for R&D in the proteomics field—major factor supporting market growth 68
10.3 EUROPE 69
10.3.1 GERMANY 72
10.3.1.1 Favorable funding scenario for life science research to drive the growth of the protein sequencing market in Germany 72
10.3.2 FRANCE 72
10.3.2.1 Rising demand for biotherapeutics and biotechnology in the country to drive the adoption of protein sequencing 72
10.3.3 UK 73
10.3.3.1 Presence of a large life sciences industry and the continued growth of the biopharmaceuticals sector are the major factors driving market growth 73
10.3.4 REST OF EUROPE 74
10.4 ASIA PACIFIC 75
10.4.1 CHINA 78
10.4.1.1 China to register the highest growth in the Asia Pacific protein sequencing market during the forecast period 78
10.4.2 JAPAN 78
10.4.2.1 Strong life sciences R&D infrastructure and a favorable government funding scenario are key factors driving market growth 78
10.4.3 INDIA 79
10.4.3.1 Implementation of favorable government initiatives to support life sciences research to support the growth of the protein sequencing market in India 79
10.4.4 REST OF ASIA PACIFIC 80
10.5 REST OF THE WORLD 81
11 COMPETITIVE LANDSCAPE 84
11.1 OVERVIEW 84
11.2 MARKET SHARE ANALYSIS 85
11.3 COMPETITIVE SITUATION AND TRENDS 86
11.3.1 PRODUCT LAUNCHES AND SERVICES 86
11.3.2 PARTNERSHIPS 87
11.3.3 ACQUISITIONS 87
11.3.4 EXPANSIONS 88
12 COMPANY PROFILES 89
(Introduction, Products & Services, Strategy, & Analyst Insights, Developments, MnM View)*
12.1 AGILENT TECHNOLOGIES, INC. 89
12.2 BIOINFORMATICS SOLUTIONS 91
12.3 CHARLES RIVER LABORATORIES 92
12.4 PROTEOME FACTORY 94
12.5 RAPID NOVOR INC. 95
12.6 SELVITA 97
12.7 SGS 99
12.8 SHIMADZU CORPORATION 101
12.9 THERMO FISHER SCIENTIFIC INC. 105
12.10 WATERS 109
*Details on MarketsandMarkets view, Introduction, Product & Services, Strategy, & Analyst Insights, New Developments might not be captured in case of unlisted companies.
13 APPENDIX 111
13.1 DISCUSSION GUIDE 111
13.2 KNOWLEDGE STORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL 115
13.3 AVAILABLE CUSTOMIZATIONS 117
13.4 RELATED REPORTS 117
13.5 AUTHOR DETAILS 118
TABLE 1 PROTEIN SEQUENCING MARKET, BY PRODUCT & SERVICE,
2016–2023 (USD MILLION) 38
TABLE 2 SAMPLE PREPARATION PRODUCTS & SERVICES MARKET, BY REGION,
2016–2023 (USD MILLION) 39
TABLE 3 PROTEIN SEQUENCING PRODUCTS MARKET, BY TYPE, 2016–2023 (USD MILLION) 40
TABLE 4 PROTEIN SEQUENCING PRODUCTS MARKET, BY REGION,
2016–2023 (USD MILLION) 40
TABLE 5 REAGENTS & CONSUMABLES MARKET, BY REGION, 2016–2023 (USD MILLION) 41
TABLE 6 INSTRUMENTS MARKET, BY TYPE, 2016–2023 (USD MILLION) 42
TABLE 7 INSTRUMENTS MARKET, BY REGION, 2016–2023 (USD MILLION) 42
TABLE 8 ANALYSIS PRODUCTS/SOFTWARE MARKET, BY REGION,
2016–2023 (USD MILLION) 44
TABLE 9 PROTEIN SEQUENCING SERVICES MARKET, BY REGION,
2016–2023 (USD MILLION) 45
TABLE 10 PROTEIN SEQUENCING MARKET, BY TECHNOLOGY, 2016–2023 (USD MILLION) 47
TABLE 11 MASS SPECTROMETRY PROTEIN SEQUENCING MARKET, BY REGION,
2016–2023 (USD MILLION) 48
TABLE 12 EDMAN DEGRADATION PROTEIN SEQUENCING MARKET, BY REGION,
2016–2023 (USD MILLION) 49
TABLE 13 PROTEIN SEQUENCING MARKET, BY APPLICATION, 2016–2023 (USD MILLION) 51
TABLE 14 PROTEIN SEQUENCING MARKET FOR BIOTHERAPEUTICS, BY REGION,
2016–2023 (USD MILLION) 52
TABLE 15 PROTEIN SEQUENCING MARKET FOR GENETIC ENGINEERING, BY REGION,
2016–2023 (USD MILLION) 53
TABLE 16 PROTEIN SEQUENCING MARKET FOR OTHER APPLICATIONS, BY REGION,
2016–2023 (USD MILLION) 55
TABLE 17 PROTEIN SEQUENCING MARKET, BY END USER, 2016–2023 (USD MILLION) 57
TABLE 18 PROTEIN SEQUENCING MARKET FOR ACADEMIC INSTITUTES & RESEARCH CENTERS, BY REGION, 2016–2023 (USD MILLION) 59
TABLE 19 PROTEIN SEQUENCING MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY REGION, 2016–2023 (USD MILLION) 60
TABLE 20 PROTEIN SEQUENCING MARKET FOR OTHER END USERS, BY REGION,
2016–2023 (USD MILLION) 61
TABLE 21 PROTEIN SEQUENCING MARKET, BY REGION, 2016–2023 (USD MILLION) 63
TABLE 22 NORTH AMERICA: PROTEIN SEQUENCING MARKET, BY PRODUCT & SERVICE, 2016–2023 (USD MILLION) 65
TABLE 23 NORTH AMERICA: PROTEIN SEQUENCING PRODUCTS MARKET, BY TYPE,
2016–2023 (USD MILLION) 65
TABLE 24 NORTH AMERICA: PROTEIN SEQUENCING MARKET, BY TECHNOLOGY,
2016–2023 (USD MILLION) 65
TABLE 25 NORTH AMERICA: PROTEIN SEQUENCING MARKET, BY APPLICATION,
2016–2023 (USD MILLION) 66
TABLE 26 NORTH AMERICA: PROTEIN SEQUENCING MARKET, BY END USER,
2016–2023 (USD MILLION) 66
TABLE 27 NORTH AMERICA: PROTEIN SEQUENCING MARKET, BY COUNTRY,
2016–2023 (USD MILLION) 66
TABLE 28 US: PROTEIN SEQUENCING MARKET, BY PRODUCT & SERVICE,
2016–2023 (USD MILLION) 67
TABLE 29 CANADA: PROTEIN SEQUENCING MARKET, BY PRODUCT & SERVICE,
2016–2023 (USD MILLION) 68
TABLE 30 EUROPE: PROTEIN SEQUENCING MARKET, BY PRODUCT & SERVICE,
2016–2023 (USD MILLION) 70
TABLE 31 EUROPE: PROTEIN SEQUENCING PRODUCTS MARKET, BY TYPE,
2016–2023 (USD MILLION) 70
TABLE 32 EUROPE: PROTEIN SEQUENCING MARKET, BY TECHNOLOGY,
2016–2023 (USD MILLION) 70
TABLE 33 EUROPE: PROTEIN SEQUENCING MARKET, BY APPLICATION,
2016–2023 (USD MILLION) 71
TABLE 34 EUROPE: PROTEIN SEQUENCING MARKET, BY END USER,
2016–2023 (USD MILLION) 71
TABLE 35 EUROPE: PROTEIN SEQUENCING MARKET, BY COUNTRY,
2016–2023 (USD MILLION) 71
TABLE 36 GERMANY: PROTEIN SEQUENCING MARKET, BY PRODUCT & SERVICE,
2016–2023 (USD MILLION) 72
TABLE 37 FRANCE: PROTEIN SEQUENCING MARKET, BY PRODUCT & SERVICE,
2016–2023 (USD MILLION) 73
TABLE 38 UK: PROTEIN SEQUENCING MARKET, BY PRODUCT & SERVICE,
2016–2023 (USD MILLION) 73
TABLE 39 REST OF EUROPE: PROTEIN SEQUENCING MARKET, BY PRODUCT & SERVICE, 2016–2023 (USD MILLION) 74
TABLE 40 ASIA PACIFIC: PROTEIN SEQUENCING MARKET, BY PRODUCT & SERVICE,
2016–2023 (USD MILLION) 76
TABLE 41 ASIA PACIFIC: PROTEIN SEQUENCING PRODUCTS MARKET, BY TYPE,
2016–2023 (USD MILLION) 76
TABLE 42 ASIA PACIFIC: PROTEIN SEQUENCING MARKET, BY TECHNOLOGY,
2016–2023 (USD MILLION) 76
TABLE 43 ASIA PACIFIC: PROTEIN SEQUENCING MARKET, BY APPLICATION,
2016–2023 (USD MILLION) 77
TABLE 44 ASIA PACIFIC: PROTEIN SEQUENCING MARKET, BY END USER,
2016–2023 (USD MILLION) 77
TABLE 45 ASIA PACIFIC: PROTEIN SEQUENCING MARKET, BY COUNTRY,
2016–2023 (USD MILLION) 77
TABLE 46 CHINA: PROTEIN SEQUENCING MARKET, BY PRODUCT & SERVICE,
2016–2023 (USD MILLION) 78
TABLE 47 JAPAN: PROTEIN SEQUENCING MARKET, BY PRODUCT & SERVICE,
2016–2023 (USD MILLION) 79
TABLE 48 INDIA: PROTEIN SEQUENCING MARKET, BY PRODUCT & SERVICE,
2016–2023 (USD MILLION) 80
TABLE 49 REST OF ASIA PACIFIC: PROTEIN SEQUENCING MARKET, BY PRODUCT & SERVICE, 2016–2023 (USD MILLION) 80
TABLE 50 ROW: PROTEIN SEQUENCING MARKET, BY PRODUCT & SERVICE,
2016–2023 (USD MILLION) 82
TABLE 51 ROW: PROTEIN SEQUENCING PRODUCTS MARKET, BY TYPE,
2016–2023 (USD MILLION) 82
TABLE 52 ROW: PROTEIN SEQUENCING MARKET, BY TECHNOLOGY,
2016–2023 (USD MILLION) 82
TABLE 53 ROW: PROTEIN SEQUENCING MARKET, BY APPLICATION,
2016–2023 (USD MILLION) 83
TABLE 54 ROW: PROTEIN SEQUENCING MARKET, BY END USER, 2016–2023 (USD MILLION) 83
TABLE 55 KEY PRODUCT AND SERVICE LAUNCHES 2017–2018 (OCTOBER) 86
TABLE 56 KEY PARTNERSHIPS, 2017–2018 (OCTOBER) 87
TABLE 57 KEY ACQUISITIONS, 2017–2018 (OCTOBER) 87
TABLE 58 KEY GEOGRAPHIC EXPANSIONS, 2017–2018 (OCTOBER) 88
LIST OF FIGURES
FIGURE 1 PROTEIN SEQUENCING MARKET: RESEARCH DESIGN 19
FIGURE 2 BREAKDOWN OF PRIMARY INTERVIEWS: BY COMPANY TYPE, DESIGNATION, & REGION 21
FIGURE 3 MARKET SIZE ESTIMATION: PROTEIN SEQUENCING MARKET 23
FIGURE 4 DATA TRIANGULATION METHODOLOGY 24
FIGURE 5 PROTEIN SEQUENCING MARKET SHARE, BY APPLICATION, 2018 VS. 2023 26
FIGURE 6 PROTEIN SEQUENCING MARKET SHARE, BY PRODUCT & SERVICE, 2018 VS. 2023 27
FIGURE 7 PROTEIN SEQUENCING MARKET, BY TECHNOLOGY, 2018 VS. 2023 (USD MILLION) 27
FIGURE 8 PROTEIN SEQUENCING MARKET, BY END USER, 2018 VS. 2023 (USD MILLION) 28
FIGURE 9 PROTEIN SEQUENCING MARKET: GEOGRAPHICAL SNAPSHOT 28
FIGURE 10 SIGNIFICANT ADOPTION OF TARGET-BASED DRUG DEVELOPMENT APPROACHES
TO DRIVE MARKET GROWTH 30
FIGURE 11 PROTEIN SEQUENCING SERVICES SEGMENT IS EXPECTED TO ACCOUNT FOR THE MAJOR SHARE DURING FORECAST PERIOD 30
FIGURE 12 MASS SPECTROMETRY WILL CONTINUE TO DOMINATE THE PROTEIN SEQUENCING MARKET IN 2023 31
FIGURE 13 BIOTHERAPEUTICS SEGMENT IS EXPECTED TO GROW AT THE HIGHEST RATE DURING THE STUDY PERIOD 31
FIGURE 14 ACADEMIC INSTITUTES AND RESEARCH CENTERS TO DOMINATE THE PROTEIN SEQUENCING MARKET IN THE FORECAST PERIOD 32
FIGURE 15 PROTEIN SEQUENCING MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, & CHALLENGES 33
FIGURE 16 NIH RESEARCH GRANTS FOR RESEARCH IN LIFE SCIENCES, 2013–2017 (USD BILLION) 35
FIGURE 17 PROTEIN SEQUENCING SERVICES ARE EXPECTED TO REGISTER HIGHEST GROWTH DURING THE FORECAST PERIOD 38
FIGURE 18 MASS SPECTROMETRY TO DOMINATE THE PROTEIN SEQUENCING MARKET DURING THE FORECAST PERIOD 47
FIGURE 19 BIOTHERAPEUTICS IS EXPECTED TO GROW AT THE HIGHEST RATE DURING THE FORECAST PERIOD 51
FIGURE 20 NUMBER OF RESEARCH PUBLICATIONS ON GENETICALLY MODIFIED ORGANISMS (2007-2017) 53
FIGURE 21 GROWTH IN THE NUMBER OF KNOWN PROTEIN STRUCTURES AVAILABLE IN PROTEIN DATA BANK DATABASE 54
FIGURE 22 ACADEMIC INSTITUTES & RESEARCH CENTERS TO REGISTER THE HIGHEST GROWTH DURING THE FORECAST PERIOD (2018–2023) 57
FIGURE 23 KEY ACADEMIC PROTEIN SEQUENCING SERVICE PROVIDERS 58
FIGURE 24 FUNDING FOR PROTEOMIC RESEARCH, 1987–2017 (USD MILLION) 59
FIGURE 25 NORTH AMERICA: PROTEIN SEQUENCING MARKET SNAPSHOT 64
FIGURE 26 EUROPE: PROTEIN SEQUENCING MARKET SNAPSHOT 69
FIGURE 27 ASIA PACIFIC: PROTEIN SEQUENCING MARKET SNAPSHOT 75
FIGURE 28 ROW: PROTEIN SEQUENCING MARKET SNAPSHOT 81
FIGURE 29 KEY DEVELOPMENTS IN THE PROTEIN SEQUENCING MARKET
FROM JAN 2015 TO OCTOBER 2018 84
FIGURE 30 PROTEIN SEQUENCING MARKET SHARE ANALYSIS, BY KEY PLAYER, 2017 85
FIGURE 31 AGILENT TECHNOLOGIES: COMPANY SNAPSHOT (2017) 89
FIGURE 32 CHARLES RIVER LABORATORIES: COMPANY SNAPSHOT (2017) 92
FIGURE 33 SELVITA: COMPANY SNAPSHOT (2017) 97
FIGURE 34 SGS: COMPANY SNAPSHOT (2017) 99
FIGURE 35 SHIMADZU CORPORATION: COMPANY SNAPSHOT (2017) 101
FIGURE 36 THERMO FISHER SCIENTIFIC: COMPANY SNAPSHOT (2017) 105
FIGURE 37 WATERS: COMPANY SNAPSHOT (2017) 109
